Live Breaking News & Updates on Division of surgery

Stay updated with breaking news from Division of surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bucks Doctor wins prestigious Evelyn Baker Award - Buckinghamshire Healthcare NHS Trust

Bucks Doctor wins prestigious Evelyn Baker Award - Buckinghamshire Healthcare NHS Trust
buckshealthcare.nhs.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from buckshealthcare.nhs.uk Daily Mail and Mail on Sunday newspapers.

Buckinghamshire , United-kingdom , Stoke-mandeville , Kumar-krishna-panikkar , Denise-stott , Division-of-surgery , Association-of-anaesthetists , Bucks-doctor , Evelyn-baker , Intensive-care , Buckinghamshire-healthcare , Evelyn-baker-award

Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Ménière's Disease

/PRNewswire/ -- Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced that...

Australia , United-states , Jafri-kuthubutheen , Division-of-surgery , Prnewswire-spiral-therapeutics-inc , Humboldt-fund , National-institute-of-deafness , Spiral-therapeutics-inc , University-of-western-australia , Savoir-capital , Catalio-capital-management , National-institute

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

First results from LIGHTHOUSE trial presented at 23rd Annual Scientific Meeting in Urologic Oncology (SUO)

Germany , San-diego , California , United-states , Munich , Bayern , Texas , Scintomics-gmb , Davide-gauden , Brianf-chapin , Technical-university-of-munich

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Invest

− First results from LIGHTHOUSE trial presented at 23rd Annual Scientific Meeting in Urologic Oncology (SUO) –MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today...

Germany , Milan , Lombardia , Italy , United-states , Munich , Bayern , United-kingdom , Texas , San-diego , California , Scintomics-gmb

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

- First results from LIGHTHOUSE trial presented at 23rd Annual Scientific Meeting in Urologic Oncology (SUO) - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and

Germany , Milan , Lombardia , Italy , United-states , Munich , Bayern , United-kingdom , Texas , San-diego , California , Scintomics-gmb

Adjuvant Atezolizumab Does Not Improve Disease-Free Survival in Patients With RCC

Adjuvant Atezolizumab Does Not Improve Disease-Free Survival in Patients With RCC
ascopost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ascopost.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Axel-bex , Division-of-surgery , Drug-administration , European-society-for-medical-oncology , Eastern-cooperative-oncology-group , Patients-with , European-society , Medical-oncology , Royal-free-london

Nonacus Welcomes Two Senior Leadership Hires: Dr Andy Feber and Dr Samuel Clokie

/PRNewswire/ -- Nonacus Ltd, leading provider of genetic testing products for precision medicine and liquid biopsy, is very pleased to announce the appointment...

New-york , United-states , United-kingdom , Edinburgh , City-of , Chris-sale , Team-lead-for-the-translational-epigenomics , Mount-sinai-medical-school-new-york , Institute-of-cancer-research-london , Prnewswire-nonacus-ltd , University-of-edinburgh , Division-of-surgery

Lung Cancer Mutation Consortium Sites Initiate LEADER Trial

/PRNewswire/ -- The Lung Cancer Mutation Consortium (LCMC), facilitated by the Lung Cancer Research Foundation (LCRF), announces the initiation of trial sites...

California , United-states , Michigan , Texas , American , Markg-kris , Sheila-sullivan , Boris-sepesi , University-of-california , American-society-of-clinical-oncology , University-of-texas-md-anderson-cancer-center , University-of-michigan

Study finds new algorithm that improves accuracy of screening for prostate cancer

A new study has discovered that calculating a person's risk of developing prostate cancer using results from two blood makers can improve the accuracy of screening for the disease.

United-kingdom , Roger-kirby , Division-of-surgery , Royal-society-of-medicine , Jonathan-bestwick-queen-mary-university-of-london , Institute-of-health-informatics , National-institute-of-clinical-excellence , Professor-sir-nicholas-wald , Health-informatics , Jonathan-bestwick , Queen-mary-university , Royal-society

New multi-marker risk algorithm could improve the accuracy of prostate cancer screening

Calculating a person's risk of developing prostate cancer using results from two blood markers would improve the accuracy of screening for the disease, reports a new study led by a UCL researcher.

United-kingdom , Nicholas-wald , Roger-kirby , Emily-henderson , Division-of-surgery , University-of-london , Queen-mary-university-of-london , Royal-society-of-medicine , Jonathan-bestwick-queen-mary-university-of-london , Institute-of-health-informatics , National-institute-of-clinical-excellence , Medical-screening